Last reviewed · How we verify

NCT03486535

Infraclavicular Block Properties in Diabetic Patients

Completed Last updated 30 July 2019
What this trial tests

trial testing Infraclavicular Brachial Plexus Blocks in Diabetes Mellitus in 60 participants. Completed in 31 January 2019.

Timeline
20 February 2018
Primary endpoint
31 January 2019
31 January 2019

Quick facts

Lead sponsorIstanbul University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment60
Start date20 February 2018
Primary completion31 January 2019
Estimated completion31 January 2019
Sites2 locations across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istanbul University

Who can join

Adults 40 to 80, any sex, with Diabetes Mellitus or Nerve Block Duration. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background and objectives: The investigators are performing this study to explore whether the presence of diabetes mellitus (DM) will affect the outcomes of infraclavicular brachial plexus blocks (ICBs) in patients undergoing elbow, forearm and hand surgery. The primary hypothesis is that the sensory block duration will be delaying in diabetic patients. Methods: Ethics committee approval has been obtained and after written informed consents, 60 patients are planning to be enrolled to the study. Diabetic patients will be included in Group DM and non-diabetics are included in Group NODM. All patients will receive ultrasound-guided ICBs with the mixture of 15 mL lidocaine 2% and 15 mL bupivacaine 0.5%. Our primary outcome is sensory block duration, and secondary outcomes are sensory and motor block onset times, motor block duration, time-to-first-pain (numeric rating scale (NRS) ≥4), postoperative NRS scores and rescue analgesic consumption (NRS) ≥4) through the postoperative first 2 days. All outcomes will be assessed by blind investigators.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Infraclavicular Brachial Plexus Blocks

Trials testing the same drug.

Other recruiting trials for Diabetes Mellitus

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03486535.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing